Status: Recruiting
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
The objective of this study was to evaluate the efficacy and safety of Herombopag in the treatment of elderly patients with ITP.
Participants needed: 80
Trial details
Phase: Phase 2Age: 60+Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Mar 13, 2025Locations: 1
Eligibility criteria
Patients voluntarily participated in the study and signed informed consent; [+7]
Patients who did not respond to previous treatment with herombopag; [+15]